A method and medicament for preventing or treating neurodegenerative diseases
The combined use of gliclazide and acetaminophen has solved the problem that existing technologies cannot effectively treat neurodegenerative diseases, and has achieved improvement and disease control in cases of olfactory impairment and cognitive dysfunction, especially in diseases related to protein aggregation such as Parkinson's disease.
CN122376602APending Publication Date: 2026-07-14PING AN SHIONOGI CO LTD
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- PING AN SHIONOGI CO LTD
- Filing Date
- 2025-01-03
- Publication Date
- 2026-07-14
Smart Images
Figure CN122376602A_ABST
Abstract
Disclosed is a method and a medicament for preventing or treating neurodegenerative diseases using or comprising a therapeutically effective amount of gliclazide or a pharmaceutically acceptable salt thereof or a combination of gliclazide or a pharmaceutically acceptable salt thereof and acetaminophen or a pharmaceutically acceptable salt thereof. The method and the medicament of the present invention can significantly improve symptoms such as hyposmia, cognitive dysfunction, psychotic symptoms, etc. of patients with neurodegenerative diseases that cannot be treated by existing drugs, and are particularly useful for controlling the progression of neurodegenerative diseases.
Need to check novelty before this filing date? Find Prior Art